Results 211 to 220 of about 24,939 (257)

Current progress of 1,2,3-triazole hybrids as EGFR inhibitors for cancer therapy - a literature review. [PDF]

open access: yesRSC Adv
Khasawneh HEN   +11 more
europepmc   +1 more source

PDE1B and PDE10A as novel targets for schizophrenia: from molecular design and synthesis to therapeutic promise. [PDF]

open access: yesFront Pharmacol
Rautela J   +6 more
europepmc   +1 more source

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF QUINAZOLINES AS ANTICONVULSANT AGENTS

open access: green
SWAPNA BATTALA   +4 more
openalex   +1 more source

Quinazolines. Part XV. Hexahydro- and octahydro-quinazolines

Journal of the Chemical Society C: Organic, 1971
3,4,5,6,7,8-Hexahydroquinazoline, obtained by catalytic reduction of 5,6,7,8-tetrahydroquinazoline, was slowly oxidised by air to the starting material in chloroform solution, but in aqueous alkali it was degraded to 2-formamidomethylcyclohexanone. trans-4a,5,6,7,8,8a-Hexahydroquinazolin-4(1 - or 3-H)-one was shown to be a tautomeric mixture of the (1H)
W. L. F. Armarego, Toshihiko Kobayashi
openaire   +1 more source

Quinazolines

ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
openaire   +1 more source

Dermatitis from quinazoline oxide

Contact Dermatitis, 1986
Dermatitis from 2‐chloromethyl‐4‐phenyl‐6‐chloroquinazoline‐3‐oxide, an intermediate product in the preparation of chlorodiazepoxide, is described in 29 workers at a pharmaceutical plant. All were patch test positive to quinazoline oxide (1%) and six to 0.05%. In most patients, the face was earlier and more severely involved than the hands.
P, Rebandel, E, Rudzki
openaire   +2 more sources

Pyrimido[4,5‐f]quinazolines.

ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
N. N. Tonkikh   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy